Primer: Fujian Wanchen Biotechnology Group (300972 CH) - Apr 2026
Fujian Wanchen has pivoted from its origins in edible fungi to become China's leading and fastest-growing bulk snack and beverage retailer,...
149 Views
Pre-IPO Fujian Wanchen Biotechnology Group - The Business Model, Peer Comparison, and the Outlook
​WANCHEN's business model relies on economies of scale but faces low profit margin and decreasing growth rate. Valuation compared to BUSY MING...
307 Views
Pre-IPO Liuliumei Co., Ltd. (PHIP Updates) - Some Points Worth the Attention
​Liuliumei shift focus to new categories but face declining margin. Dividend seen as cash-out before IPO damages governance image.16-20x PE is...
85 Views
Pre-IPO Jintan - About the Business Model, the Risks and the Peer Comparison
​Jintan's "IP+ snack" model leads niche market but face risk.Revenue expected to be up 10% in 2025, with potential for 15%/12% in 2026/27.Valuation...
223 Views
Busy Ming Group (1768 HK) IPO - Thoughts on Valuation and the Outlook
​BUSY MING's attractive IPO pricing leaves upside potential, but concerns arise over franchisee profits and sustainability of growth model....
513 Views